BioCytics Inc
Don Jackson is a highly experienced professional who has held key leadership positions in various technology and healthcare companies. With a background in computer science, Don has been instrumental in the development and implementation of innovative technologies in the healthcare sector. Throughout his career, Don has exhibited a strong track record of successfully leading and growing SaaS technology companies, focusing on areas such as clinical information systems, biotech decision support, and early detection and intervention for cancer and chronic diseases. Currently serving as the Chief Operating Officer at BioCytics Inc, Don continues to drive the development of autologous cellular therapies to improve patient outcomes.
This person is not in any teams
BioCytics Inc
BioCytics via the Human Applications Lab is focused on bringing personalized oncology treatments to the market. BioCytics has an ongoing IRB-approved clinical trial (BioCytics 0001; NCT00571389) that allows for the collection and study of blood and tissue samples from consenting cancer patients. We are incubated within Carolina BioOncology - a preferred cancer treatment and Phase I drug testing facility. BioCytics was founded by Dr. John Powderly, MD, medical board certified oncologist and a certified physician investigator (CPI), who is also president of Carolina BioOncology Institute (CBOI).